/Labcorp%20Holdings%20Inc_%20logo%20magnified-by%20ll_studio%20via%20Shutterstock.jpg)
Burlington, North Carolina-based Labcorp Holdings Inc. (LH) operates in the healthcare diagnostics and biopharma sectors. With a market cap of $18.2 billion, the company offers comprehensive clinical laboratory services and drug development support, helping healthcare providers and patients make informed decisions. The company is scheduled to release its fiscal Q3 earnings results before the market opens on Thursday, Oct. 24.
Ahead of this event, analysts expect the medical laboratory operator to report a profit of $3.50 per share, up 3.6% from $3.38 per share in the previous year's quarter. The company has surpassed Wall Street's bottom-line estimates in the past four quarters. In the most recent quarter, the company exceeded the consensus estimate by 4.2%.